The OVX model is commonly used to study metabolic diseases associated with estrogen deficiency, and it shows fundamental changes in insulin sensitivity, glucose tolerance, and body weight (Araujo et al. 2023; Baudin et al. 2024). This evidence concerns the gene INS and metabolic disease.